Immunoproteasome subunit LMP2 is crucial for lymphocyte survival and is a pro-survival factor for human multiple myeloma

被引:0
|
作者
Zanker, D. [1 ]
Pang, K. [2 ]
Oveissi, S. [1 ]
Lu, C. [1 ]
Neeson, P. [3 ]
Puthalakath, H. [1 ]
Chen, W. [1 ]
机构
[1] La Trobe Inst Mol Sci, Bundoora, Vic, Australia
[2] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[3] Peter MacCallum Canc Ctr, East Melbourne, Australia
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
845
引用
收藏
页码:886 / 886
页数:1
相关论文
共 50 条
  • [31] Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1
    Spaan, Ingrid
    van de Stolpe, Anja
    Raymakers, Reinier A.
    Peperzak, Victor
    CANCERS, 2021, 13 (18)
  • [32] TMEM63C is a pro-survival factor in angiotensin II-treated human glomerular epithelial cells
    Eisenreich, A.
    Orphal, M.
    Gillespie, A.
    Kreutz, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S41 - S41
  • [33] Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
    GeorgiiHemming, P
    Wiklund, HJ
    Ljunggren, O
    Nilsson, K
    BLOOD, 1996, 88 (06) : 2250 - 2258
  • [34] Expression of Bcl-2 pro-survival family proteins predicts pharmacological responses to ABT-199, a novel and selective Bcl-2 antagonist, in multiple myeloma models
    Sampath, Deepak
    Punnoose, Elizabeth
    Beghaert, Erwin
    Belmont, Lisa
    Peale, Franklin
    Nguyen Tan
    Chen, Jun
    Darbonne, Walter
    Yue, Peng
    Oeh, Jason
    Lee, Leslie
    Fairbrother, Wayne J.
    Souers, Andrew J.
    Elmore, Steven W.
    Leverson, Joel D.
    CANCER RESEARCH, 2013, 73 (08)
  • [35] Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma
    Barbarulo, A.
    Iansante, V.
    Chaidos, A.
    Naresh, K.
    Rahemtulla, A.
    Franzoso, G.
    Karadimitris, A.
    Haskard, D. O.
    Papa, S.
    Bubici, C.
    ONCOGENE, 2013, 32 (36) : 4231 - 4242
  • [36] Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma
    A Barbarulo
    V Iansante
    A Chaidos
    K Naresh
    A Rahemtulla
    G Franzoso
    A Karadimitris
    D O Haskard
    S Papa
    C Bubici
    Oncogene, 2013, 32 : 4231 - 4242
  • [37] Alternate Splicing Factor Fox2 Affects Growth and Survival of Multiple Myeloma Cells
    Song, Weihua
    Hu, Yiguo
    Yang, Guang
    Shah, Parantu K.
    Shan, Weisong
    Tai, Yu-Tzu
    Li, Yi
    Minvielle, Stephane
    Avet-Loiseau, Herve
    Anderson, Kenneth C.
    Li, Cheng
    Munshi, Nikhil C.
    BLOOD, 2011, 118 (21) : 790 - 790
  • [38] Expression of Bcl-2 Pro-Survival Family Proteins Predicts Pharmacological Responses to ABT-199, a Novel and Selective Bc1-2 Antagonist, in Multiple Myeloma Models
    Sampath, Deepak
    Punnoose, Elizabeth
    Boghaert, Erwin R.
    Belmont, Lisa
    Chen, Jun
    Peale, Franklin
    Nguyen Tan
    Darbonne, Walter
    Yue, Peng
    Oeh, Jason
    Lee, Leslie
    Fairbrother, Wayne J.
    Souers, Andrew J.
    Elmore, Steve W.
    Leverson, Joel D.
    BLOOD, 2012, 120 (21)
  • [39] Co-Treatment of Bortezomib and PRIMA-1Met Synergistically Overcomes Drug Resistance by Down-Regulating Pro-Survival Autophagy in Multiple Myeloma
    Wang, Minjing
    Zhang, Lun
    Rastgoo, Nasrin
    Abdi, Jahangir
    Chang, Hong
    MODERN PATHOLOGY, 2017, 30 : 383A - 384A
  • [40] Co-Treatment of Bortezomib and PRIMA-1Met Synergistically Overcomes Drug Resistance by Down-Regulating Pro-Survival Autophagy in Multiple Myeloma
    Wang, Minjing
    Zhang, Lun
    Rastgoo, Nasrin
    Abdi, Jahangir
    Chang, Hong
    LABORATORY INVESTIGATION, 2017, 97 : 383A - 384A